Pharmacological management of treatment-resistant obsessive-compulsive disorder. - Wikidata - wikimedia - TriplyDB

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q37893636

about

Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach 50 years of hurdles and hope in anxiolytic drug discovery The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake.Deep brain stimulation (DBS) at the interface of neurology and psychiatry Adjunctive Low-frequency Repetitive Transcranial Magnetic Stimulation over the Right Dorsolateral Prefrontal Cortex in Patients with Treatment-resistant Obsessive-compulsive Disorder: A Randomized Controlled Trial.Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.Obsessive-compulsive disorder: Evidence-based treatments and future directions for research Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity.Emerging drugs to treat obsessive-compulsive disorder.An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.Family accommodation in adult obsessive-compulsive disorder: clinical perspectives Vitamin D levels in children and adolescents with obsessive compulsive disorder.Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood.Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.

P2860

Q21285010-91540A55-0966-4487-914F-4E33E0C19522 Q26774013-96BB2AB2-644C-4E5C-A94D-786EAA5B7082 Q28297569-4E34A80D-3D7C-40A8-81BC-0320BA62AB45 Q28391257-4E7A74DA-6AFC-4125-B72C-79FC9DB758C8 Q34381701-B6820326-3831-4A46-993F-694C2D1F165B Q36873022-63A2CE0E-9CE5-4B27-897C-E4B9981C6F71 Q37099618-15C23077-BD08-4964-A219-FA2B7EE457D7 Q37195340-936B4C69-0602-484C-906B-229429EB3DE3 Q38092129-4605BDA1-260C-41C6-A586-B1BBC8B3DE6D Q38157123-4D909E51-1A84-4F43-B16A-448175B1360C Q38174649-38D4404D-262A-419C-8355-6AD5F7CAB6DE Q38207094-EA404F4C-A418-4B4F-A867-4B824AF223B2 Q39284667-86753600-7077-4125-95C3-2B4097F11462 Q42364440-7B8118EA-362C-4403-A8D4-4608D2EB0C39 Q47698811-5BDFE007-F945-4EE0-A52B-2C3B5D7FFAAF Q48943125-EC4D2600-21F5-4869-B7D7-80B1087BB2E7 Q50665402-8CB584B1-0CA4-401D-8976-8BE18CD6F05C

P2860

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q37893636

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@en

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@nl

type

label

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@en

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@nl

prefLabel

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@en

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@nl

P1433

Q37893636-EF2ED350-7C81-4990-8212-5594E2CC6E9F

P1476

Q37893636-8053A3B0-678D-406D-8D8A-531AAB9EEAAF

P2093

Q37893636-02E94528-F031-48CD-A062-77BD5C5CB962

Q37893636-92987F12-5094-44DF-92E5-7F4B426C6125

Q37893636-ADBD000E-CACC-41F2-8D1E-10634CD15208

P2860

Q37893636-03A37D7B-14DE-4B87-A584-8C359F9CE606

Q37893636-04337BE6-9AC9-4422-B905-D6F2DD18BFD2

Q37893636-08243B0C-67F0-4612-8066-D9DC06F52FB9

Q37893636-09F5D0C4-C2A7-4C14-BEC2-8A18DE0E086A

Q37893636-11CEEB98-EEF1-4166-B1AE-380B30F9F297

Q37893636-13467763-6CC3-45C2-A831-82DB8D4AE700

Q37893636-157DA6C7-09F9-4A67-B92F-D2AD26A66879

Q37893636-18582F62-F5DF-43E7-BCAD-F7F4B0936693

Q37893636-1AD4C968-E25D-4E95-B7E4-ED48789DD705

Q37893636-1C921882-8094-4AC2-8098-C87BE91341D5

P2888

Q37893636-DDDCFBD7-DA91-4498-ABC2-194E62291BFF

P304

Q37893636-21AB4CFE-AF81-4115-9C8B-4C4CC3DEFA54

P31

Q37893636-C5A43C9F-4FDA-41DD-B091-4211D028D2DE

P356

Q37893636-5529A29B-49CF-4FC1-8478-2337198635EA

P433

Q37893636-E409EC2C-874D-462D-8429-6FC70225C3AE

P478

Q37893636-E187B262-6EBA-4073-AA8C-9F552BFD4AE4

P577

Q37893636-A0C50583-3804-4BA0-B1A1-DAB97E65C3AC

P6179

Q37893636-26E454BB-B358-4B12-A352-5A020EB03C42

P698

Q37893636-B065EB4A-D540-4136-B143-BF45F2E25E1F

P921

Q37893636-CEA5A6C2-E972-4ED0-A3E0-DB1216989F63

P356

11587860-000000000-00000

P1433

P1476

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

@en

P2093

Alzbeta Juven-Wetzler

http://www.w3.org/2001/XMLSchema#string

Anat Abudy

http://www.w3.org/2001/XMLSchema#string

Joseph Zohar

http://www.w3.org/2001/XMLSchema#string

P2860

Current trends in drug treatment of obsessive–compulsive disorder

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

Nicotine treatment of obsessive-compulsive disorder.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

D-amphetamine in obsessive-compulsive disorder.

A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.

Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.

P2888

11587860-000000000-00000

P304

585-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11587860-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023967318

http://www.w3.org/2001/XMLSchema#string

P698

21699270

http://www.w3.org/2001/XMLSchema#string

P921